SCHEMBL2250848

SCHEMBL2250848

COc1ccc(C#Cc2cc(CO)c(N3C[C@@H](C)O[C@@H](C)C3)nc2F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MTOR P42345 7/20 0.37
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
KCNH2 Q12809 1/20 0.37
RICTOR Q6R327 1/20 0.37
RPTOR Q8N122 1/20 0.37
MAPKAP1 Q9BPZ7 1/20 0.37
MLST8 Q9BVC4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 5/20 0.37
ALDH1A1 P00352 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
KMT2A Q03164 2/20 0.37
HPGD P15428 1/20 0.37
MDM2 Q00987 1/20 0.37
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
GRM3 Q14832 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2250852 1.00 TSHR (0.38) TSHRNPSR1MTORPIK3CDPIK3CA
SCHEMBL2216696 0.82 TSHR (0.40) TSHRNPSR1MTORPIK3CAL3MBTL1
SCHEMBL2215049 0.78 ALDH1A1 (0.38) TSHRNPSR1MTORPIK3CDPIK3CA
SCHEMBL2216378 0.77 KDM4E (0.36) MTORPIK3CDPIK3CAKCNH2RICTOR
SCHEMBL2213719 0.73 ALDH1A1 (0.39) TSHRNPSR1MTORPIK3CDPIK3CA
SCHEMBL2212612 0.69 TSHR (0.42) TSHRNPSR1MTORPIK3CAL3MBTL1
SCHEMBL2212616 0.69 TSHR (0.42) TSHRNPSR1MTORPIK3CAL3MBTL1
SCHEMBL2214720 0.67 TOP2A (0.46)
SCHEMBL8774387 0.67 APP (0.46) KCNH2L3MBTL1ALDH1A1KMT2A
SCHEMBL9159082 0.65 APP (0.47) KCNH2KDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178064-A1 SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL ASTRAZENECA R&D (SE) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178064-A1 SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL TBCA, TUBA1A, BROX TSHR 3897/4885NPSR1 2010/4885MTOR 722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.